NRXP Earnings

NRXP reported its FY2025Q1 earnings on 2025-05-15, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was -0.34, surpassing the expected -0.25 by -36% . The stock experienced a 2.08% price change on the earnings day and a 9.58% change over the next five days, reflecting market reactions to the results.

Following NRXP's FY2025Q1 earnings announcement on 2025-05-15, the stock price moved by 2.08% on the day of the release. Over the subsequent five days, it saw a 9.58% change. Historically, NRXP's stock price tends to shift by an average of -3.37% in the 10 days leading up to earnings and -0.43% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate NRXP’s annual revenue to reach 8.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -30.82% and EPS estimates Revise Downward by -9.02% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between NRXP's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -30.82%, while EPS estimates moved Revise Downward by -9.02% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, NRXP's stock price typically moves by -3.37% in the 10 days before its earnings and -0.43% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 8.00M.

The company's financial performance shows increased losses and limited revenue, but it has a stronger cash position. The strategic plan highlights promising drug developments and market opportunities, yet faces significant market, operational, and scientific risks. The Q&A session reveals some optimism about regulatory paths but also uncertainty and vague responses. Overall, the mixed signals suggest a neutral sentiment, with potential for both positive and negative developments.